DOI: 10.1055/s-00000094

Zeitschrift für Gastroenterologie

References

Amiot A, Serrero M, Peyrin-Biroulet L. et al.
One-year effectiveness and safety of vedolizumab therapy for inflammatory bowel disease: a prospective multicentre cohort study.

Aliment Pharmacol Ther 2017;
46: 310-321

Amiot A, Serrero M, Peyrin-Biroulet L. et al.
One-year effectiveness and safety of vedolizumab therapy for inflammatory bowel disease: a prospective multicentre cohort study.

Aliment Pharmacol Ther 2017;
46: 310-321

Download Bibliographical Data

Search in:
Access: